{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:55:16Z","timestamp":1782377716978,"version":"3.54.5"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00415-024-12827-x","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T15:08:54Z","timestamp":1734361734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"272","author":[{"given":"Omid","family":"Mirmosayyeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Yazdan Panah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Moases Ghaffary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Vaheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Ghoshouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Shaygannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandor K.","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"12827_CR1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fneur.2020.00450","volume":"11","author":"J Kuchling","year":"2020","unstructured":"Kuchling J, Paul F (2020) Visualizing the central nervous system: imaging tools for multiple sclerosis and neuromyelitis optica spectrum disorders. Front Neurol 11:450","journal-title":"Front Neurol"},{"issue":"5","key":"12827_CR2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/biomedicines8050130","volume":"8","author":"M Marrodan","year":"2020","unstructured":"Marrodan M, Gait\u00e1n MI, Correale J (2020) Spinal cord involvement in ms and other demyelinating diseases. Biomedicines 8(5):130","journal-title":"Biomedicines"},{"issue":"14","key":"12827_CR3","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS. Mult Scler J 26(14):1816\u20131821","journal-title":"Mult Scler J"},{"issue":"6","key":"12827_CR4","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s10072-023-06617-y","volume":"44","author":"S Bagherieh","year":"2023","unstructured":"Bagherieh S et al (2023) Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis. Neurol Sci 44(6):1905\u20131915","journal-title":"Neurol Sci"},{"key":"12827_CR5","unstructured":"Holzer H, Characterisation of Anti-Aquaporin-1 and Anti-Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorders (NMOSD). Medical University of Innsbruck"},{"issue":"1","key":"12827_CR6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.12794","volume":"1366","author":"SJ Pittock","year":"2016","unstructured":"Pittock SJ, Lucchinetti CF (2016) Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci 1366(1):20\u201339","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"12827_CR7","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1212\/NXI.0000000000000363","volume":"4","author":"A Gahlen","year":"2017","unstructured":"Gahlen A et al (2017) Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS. Neurol Neuroimmunol Neuroinflamm 4(4):e363","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"12827_CR8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0009-9260(03)00089-8","volume":"58","author":"P Pretorius","year":"2003","unstructured":"Pretorius P, Quaghebeur G (2003) The role of MRI in the diagnosis of MS. Clin Radiol 58(6):434\u2013448","journal-title":"Clin Radiol"},{"issue":"14","key":"12827_CR9","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1177\/1352458518815596","volume":"25","author":"C Chien","year":"2019","unstructured":"Chien C et al (2019) Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity. Mult Scler J 25(14):1926\u20131936","journal-title":"Mult Scler J"},{"issue":"2","key":"12827_CR10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/13524585211018987","volume":"28","author":"S Messina","year":"2022","unstructured":"Messina S et al (2022) Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis. Mult Scler J 28(2):217\u2013227","journal-title":"Mult Scler J"},{"issue":"3","key":"12827_CR11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cei.13630","volume":"206","author":"L Clarke","year":"2021","unstructured":"Clarke L et al (2021) Magnetic resonance imaging in neuromyelitis optica spectrum disorder. Clin Exp Immunol 206(3):251\u2013265","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"12827_CR12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.25411","volume":"85","author":"L Cacciaguerra","year":"2019","unstructured":"Cacciaguerra L et al (2019) Brain and cord imaging features in neuromyelitis optica spectrum disorders. Ann Neurol 85(3):371\u2013384","journal-title":"Ann Neurol"},{"issue":"3","key":"12827_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/19714009221124308","volume":"36","author":"M Darakdjian","year":"2023","unstructured":"Darakdjian M et al (2023) MRI pattern in acute optic neuritis: Comparing multiple sclerosis, NMO and MOGAD. Neuroradiol J 36(3):267\u2013272","journal-title":"Neuroradiol J"},{"issue":"1\u20132","key":"12827_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2015.05.013","volume":"355","author":"MA Mealy","year":"2015","unstructured":"Mealy MA et al (2015) Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis. J Neurol Sci 355(1\u20132):59\u201363","journal-title":"J Neurol Sci"},{"issue":"12","key":"12827_CR15","doi-asserted-by":"publisher","first-page":"e0312421","DOI":"10.1371\/journal.pone.0312421","volume":"19","author":"O Mirmosayyeb","year":"2024","unstructured":"Mirmosayyeb O, Yazdan Panah M, Mokary Y, Mohammadi M, Moases Ghaffary E, Shaygannejad V, Weinstock-Guttman B, Zivadinov R, Jakimovski D (2024) Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and metaanalysis. PLoS One. 19(12):e0312421. https:\/\/doi.org\/10.1371\/journal.pone.0312421. PMID: 39637162","journal-title":"PLoS One"},{"issue":"7","key":"12827_CR16","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3174\/ajnr.A5663","volume":"39","author":"H Tatekawa","year":"2018","unstructured":"Tatekawa H et al (2018) Imaging differences between neuromyelitis optica spectrum disorders and multiple sclerosis: a multi-institutional study in Japan. Am J Neuroradiol 39(7):1239\u20131247","journal-title":"Am J Neuroradiol"},{"issue":"5","key":"12827_CR17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/jon.13137","volume":"33","author":"E Carnero Contentti","year":"2023","unstructured":"Carnero Contentti E et al (2023) MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease. J Neuroimaging 33(5):688\u2013702","journal-title":"J Neuroimaging"},{"issue":"8","key":"12827_CR18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1177\/1352458519849517","volume":"26","author":"E Carnero Contentti","year":"2020","unstructured":"Carnero Contentti E et al (2020) Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients. Mult Scler J 26(8):945\u2013954","journal-title":"Mult Scler J"},{"key":"12827_CR19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"6","key":"12827_CR20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria.\u201d Ann Neurol 58(6):840\u2013846","journal-title":"Ann Neurol"},{"issue":"2","key":"12827_CR21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"2","key":"12827_CR22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"issue":"10","key":"12827_CR23","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485\u20131489","journal-title":"Neurology"},{"issue":"2","key":"12827_CR24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","journal-title":"Neurology"},{"issue":"4","key":"12827_CR25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.13105\/wjma.v5.i4.80","volume":"5","author":"C Luchini","year":"2017","unstructured":"Luchini C et al (2017) Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. World J Meta-Anal 5(4):80\u201384","journal-title":"World J Meta-Anal"},{"issue":"8","key":"12827_CR26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D","volume":"17","author":"RJ Hardy","year":"1998","unstructured":"Hardy RJ, Thompson SG (1998) Detecting and describing heterogeneity in meta-analysis. Stat Med 17(8):841\u2013856","journal-title":"Stat Med"},{"issue":"7568","key":"12827_CR27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","volume":"333","author":"J Lau","year":"2006","unstructured":"Lau J et al (2006) The case of the misleading funnel plot. BMJ 333(7568):597\u2013600","journal-title":"BMJ"},{"issue":"7109","key":"12827_CR28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"issue":"4","key":"12827_CR29","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088\u20131101","journal-title":"Biometrics"},{"issue":"10","key":"12827_CR30","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209303","volume":"102","author":"L Cacciaguerra","year":"2024","unstructured":"Cacciaguerra L et al (2024) Radiologic lag and brain MRI lesion dynamics during attacks in MOG antibody-associated disease. Neurology 102(10):e209303","journal-title":"Neurology"},{"issue":"6","key":"12827_CR31","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/13524585221150743","volume":"29","author":"NH Chia","year":"2023","unstructured":"Chia NH et al (2023) Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler J 29(6):748\u2013752","journal-title":"Mult Scler J"},{"issue":"1","key":"12827_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/13524585211007086","volume":"28","author":"JR Ciotti","year":"2022","unstructured":"Ciotti JR et al (2022) Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. Mult Scler J 28(1):49\u201360","journal-title":"Mult Scler J"},{"key":"12827_CR33","volume":"42","author":"F Silveira","year":"2020","unstructured":"Silveira F et al (2020) Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population. Mult Scler Relat Disorders 42:102049","journal-title":"Mult Scler Relat Disorders"},{"key":"12827_CR34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.nicl.2016.05.014","volume":"11","author":"P Manogaran","year":"2016","unstructured":"Manogaran P et al (2016) Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica. NeuroImage Clin 11:743\u2013750","journal-title":"NeuroImage Clin"},{"issue":"6","key":"12827_CR35","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/13524585241240420","volume":"30","author":"A Bianchi","year":"2024","unstructured":"Bianchi A et al (2024) Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein\u2013associated disease. Mult Scler J 30(6):674\u2013686","journal-title":"Mult Scler J"},{"issue":"3","key":"12827_CR36","doi-asserted-by":"crossref","first-page":"fcad107","DOI":"10.1093\/braincomms\/fcad107","volume":"5","author":"V Camera","year":"2023","unstructured":"Camera V et al (2023) Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease. Brain Commun 5(3):fcad107","journal-title":"Brain Commun"},{"issue":"3","key":"12827_CR37","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1212\/WNL.0000000000201465","volume":"100","author":"R Cortese","year":"2023","unstructured":"Cortese R et al (2023) Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging. Neurology 100(3):e308\u2013e323","journal-title":"Neurology"},{"issue":"3","key":"12827_CR38","doi-asserted-by":"crossref","first-page":"e1147","DOI":"10.1212\/NXI.0000000000001147","volume":"9","author":"J M\u00fcller","year":"2022","unstructured":"M\u00fcller J et al (2022) Choroid plexus volume in multiple sclerosis vs neuromyelitis optica spectrum disorder: a retrospective, cross-sectional analysis. Neurol Neuroimmunol Neuroinflamm 9(3):e1147","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"12827_CR39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/RLI.0000000000000735","volume":"56","author":"MA Rocca","year":"2021","unstructured":"Rocca MA et al (2021) Deep learning on conventional magnetic resonance imaging improves the diagnosis of multiple sclerosis mimics. Invest Radiol 56(4):252\u2013260","journal-title":"Invest Radiol"},{"issue":"6","key":"12827_CR40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/1352458520941493","volume":"27","author":"L Cacciaguerra","year":"2021","unstructured":"Cacciaguerra L et al (2021) Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approach. Mult Scler J 27(6):841\u2013854","journal-title":"Mult Scler J"},{"issue":"3","key":"12827_CR41","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s00415-021-10727-y","volume":"269","author":"L Cacciaguerra","year":"2021","unstructured":"Cacciaguerra L et al (2021) Application of deep-learning to the seronegative side of the NMO spectrum. J Neurol 269(3):1546\u20131556","journal-title":"J Neurol"},{"issue":"1","key":"12827_CR42","doi-asserted-by":"crossref","first-page":"6492786","DOI":"10.1155\/2020\/6492786","volume":"2020","author":"A Pudlac","year":"2020","unstructured":"Pudlac A et al (2020) Deep gray matter iron content in neuromyelitis optica and multiple sclerosis. Biomed Res Int 2020(1):6492786","journal-title":"Biomed Res Int"},{"issue":"12","key":"12827_CR43","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/jamaneurol.2019.2478","volume":"76","author":"T Sinnecker","year":"2019","unstructured":"Sinnecker T et al (2019) Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol 76(12):1446\u20131456","journal-title":"JAMA Neurol"},{"issue":"1","key":"12827_CR44","doi-asserted-by":"crossref","first-page":"14378","DOI":"10.1038\/s41598-019-50928-0","volume":"9","author":"I-J Chou","year":"2019","unstructured":"Chou I-J et al (2019) Reduced myelin signal in normal-appearing white matter in neuromyelitis optica measured by 7T magnetic resonance imaging. Sci Rep 9(1):14378","journal-title":"Sci Rep"},{"issue":"3","key":"12827_CR45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ophtha.2018.06.022","volume":"126","author":"T Shen","year":"2019","unstructured":"Shen T et al (2019) Differing structural and functional patterns of optic nerve damage in multiple sclerosis and neuromyelitis optica spectrum disorder. Ophthalmology 126(3):445\u2013453","journal-title":"Ophthalmology"},{"issue":"14","key":"12827_CR46","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1212\/WNL.0000000000005256","volume":"90","author":"R Cortese","year":"2018","unstructured":"Cortese R et al (2018) Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology 90(14):e1183\u2013e1190","journal-title":"Neurology"},{"issue":"4","key":"12827_CR47","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1212\/NXI.0000000000000259","volume":"3","author":"T Sinnecker","year":"2016","unstructured":"Sinnecker T et al (2016) MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T. Neurol Neuroimmunol Neuroinflamm 3(4):e259","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"12827_CR48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137715","volume":"10","author":"L Matthews","year":"2015","unstructured":"Matthews L et al (2015) Imaging surrogates of disease activity in neuromyelitis optica allow distinction from multiple sclerosis. PLoS ONE 10(9):e0137715","journal-title":"PLoS ONE"},{"issue":"6","key":"12827_CR49","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/1352458514554051","volume":"21","author":"K Weier","year":"2015","unstructured":"Weier K et al (2015) The role of cerebellar abnormalities in neuromyelitis optica\u2013a comparison with multiple sclerosis and healthy controls. Mult Scler J 21(6):757\u2013766","journal-title":"Mult Scler J"},{"issue":"7","key":"12827_CR50","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.0b013e3182648bc8","volume":"79","author":"T Sinnecker","year":"2012","unstructured":"Sinnecker T et al (2012) Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 79(7):708\u2013714","journal-title":"Neurology"},{"key":"12827_CR51","volume":"70","author":"Y Xie","year":"2023","unstructured":"Xie Y et al (2023) Structural covariance in subcortical regions in multiple sclerosis and neuromyelitis optica spectrum disorders: an MRI-based study with automated brain volumetry. Mult Scler Relat Disorders 70:104516","journal-title":"Mult Scler Relat Disorders"},{"issue":"1","key":"12827_CR52","volume":"307","author":"W Kim","year":"2022","unstructured":"Kim W et al (2022) \u03c7-Separation imaging for diagnosis of multiple sclerosis versus neuromyelitis optica spectrum disorder. Radiology 307(1):e220941","journal-title":"Radiology"},{"issue":"1","key":"12827_CR53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jnnp-2022-329680","volume":"94","author":"R Wei","year":"2023","unstructured":"Wei R et al (2023) Brain age gap in neuromyelitis optica spectrum disorders and multiple sclerosis. J Neurol Neurosurg Psychiatry 94(1):31\u201337","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12827_CR54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120205","volume":"436","author":"S Kato","year":"2022","unstructured":"Kato S et al (2022) Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: evaluation by advanced diffusion imaging. J Neurol Sci 436:120205","journal-title":"J Neurol Sci"},{"issue":"5","key":"12827_CR55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/13524585211032800","volume":"28","author":"F Zheng","year":"2022","unstructured":"Zheng F et al (2022) Structural and functional hippocampal alterations in multiple sclerosis and neuromyelitis optica spectrum disorder. Mult Scler J 28(5):707\u2013717","journal-title":"Mult Scler J"},{"issue":"7","key":"12827_CR56","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/jnr.25035","volume":"100","author":"C Andica","year":"2022","unstructured":"Andica C et al (2022) Multimodal magnetic resonance imaging quantification of gray matter alterations in relapsing-remitting multiple sclerosis and neuromyelitis optica spectrum disorder. J Neurosci Res 100(7):1395\u20131412","journal-title":"J Neurosci Res"},{"issue":"1","key":"12827_CR57","first-page":"9917582","volume":"2021","author":"I Adibi","year":"2021","unstructured":"Adibi I et al (2021) Quantitative magnetic resonance imaging analysis of early markers of upper cervical cord atrophy in multiple sclerosis and neuromyelitis optica spectrum disorder. Mult Scler Int 2021(1):9917582","journal-title":"Mult Scler Int"},{"key":"12827_CR58","doi-asserted-by":"crossref","first-page":"102867","DOI":"10.1016\/j.nicl.2021.102867","volume":"32","author":"J Huang","year":"2021","unstructured":"Huang J et al (2021) Relayed nuclear overhauser effect weighted (rNOEw) imaging identifies multiple sclerosis. NeuroImage Clin 32:102867","journal-title":"NeuroImage Clin"},{"issue":"4","key":"12827_CR59","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3988\/jcn.2020.16.4.562","volume":"16","author":"J Jang","year":"2020","unstructured":"Jang J et al (2020) Paramagnetic rims in multiple sclerosis and neuromyelitis optica spectrum disorder: a quantitative susceptibility mapping study with 3-T MRI. J Clin Neurol (Seoul, Korea) 16(4):562","journal-title":"J Clin Neurol (Seoul, Korea)"},{"key":"12827_CR60","volume":"41","author":"N Zhang","year":"2020","unstructured":"Zhang N et al (2020) Differentiate aquaporin-4 antibody negative neuromyelitis optica spectrum disorders from multiple sclerosis by multimodal advanced MRI techniques. Mult Scler Relat Disorders 41:102035","journal-title":"Mult Scler Relat Disorders"},{"issue":"4","key":"12827_CR61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224419","volume":"15","author":"H Masuda","year":"2020","unstructured":"Masuda H et al (2020) Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis. PLoS ONE 15(4):e0224419","journal-title":"PLoS ONE"},{"key":"12827_CR62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12311-019-01018-4","volume":"18","author":"S-U Lee","year":"2019","unstructured":"Lee S-U et al (2019) Comparison of ocular motor findings between neuromyelitis optica spectrum disorder and multiple sclerosis involving the brainstem and cerebellum. Cerebellum 18:511\u2013518","journal-title":"Cerebellum"},{"issue":"9","key":"12827_CR63","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/0284185116683575","volume":"58","author":"Y Duan","year":"2017","unstructured":"Duan Y et al (2017) Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study. Acta Radiol 58(9):1132\u20131137","journal-title":"Acta Radiol"},{"issue":"6","key":"12827_CR64","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/jmri.25866","volume":"47","author":"CY Lee","year":"2018","unstructured":"Lee CY et al (2018) Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders. J Magn Reson Imaging 47(6):1601\u20131609","journal-title":"J Magn Reson Imaging"},{"key":"12827_CR65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.msard.2017.02.003","volume":"13","author":"M Fan","year":"2017","unstructured":"Fan M et al (2017) Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody. Mult Scler Relat Disorders 13:58\u201366","journal-title":"Mult Scler Relat Disorders"},{"issue":"8","key":"12827_CR66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184012","volume":"12","author":"H Masuda","year":"2017","unstructured":"Masuda H et al (2017) Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder. PLoS ONE 12(8):e0184012","journal-title":"PLoS ONE"},{"issue":"14","key":"12827_CR67","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1177\/1352458516636246","volume":"22","author":"S-H Kim","year":"2016","unstructured":"Kim S-H et al (2016) Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler J 22(14):1850\u20131858","journal-title":"Mult Scler J"},{"issue":"12","key":"12827_CR68","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1177\/1352458516636247","volume":"22","author":"IH Jeong","year":"2016","unstructured":"Jeong IH et al (2016) Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder. Mult Scler J 22(12):1616\u20131620","journal-title":"Mult Scler J"},{"issue":"2","key":"12827_CR69","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/ene.13224","volume":"24","author":"JW Hyun","year":"2017","unstructured":"Hyun JW et al (2017) Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis. Eur J Neurol 24(2):437\u2013445","journal-title":"Eur J Neurol"},{"issue":"23","key":"12827_CR70","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1212\/WNL.0000000000003395","volume":"87","author":"A Eshaghi","year":"2016","unstructured":"Eshaghi A et al (2016) Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest. Neurology 87(23):2463\u20132470","journal-title":"Neurology"},{"issue":"3","key":"12827_CR71","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1148\/radiol.2015142786","volume":"277","author":"Y Liu","year":"2015","unstructured":"Liu Y et al (2015) Multimodal quantitative MR imaging of the thalamus in multiple sclerosis and neuromyelitis optica. Radiology 277(3):784\u2013792","journal-title":"Radiology"},{"key":"12827_CR72","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.nicl.2015.01.001","volume":"7","author":"A Eshaghi","year":"2015","unstructured":"Eshaghi A et al (2015) Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis. NeuroImage Clin 7:306\u2013314","journal-title":"NeuroImage Clin"},{"issue":"4","key":"12827_CR73","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/1352458513499420","volume":"20","author":"L Zhang","year":"2014","unstructured":"Zhang L et al (2014) Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica. Mult Scler J 20(4):418\u2013423","journal-title":"Mult Scler J"},{"issue":"6","key":"12827_CR74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1756285617708911","volume":"10","author":"UW Kaunzner","year":"2017","unstructured":"Kaunzner UW, Gauthier SA (2017) MRI in the assessment and monitoring of multiple sclerosis: an update on best practice. Ther Adv Neurol Disord 10(6):247\u2013261","journal-title":"Ther Adv Neurol Disord"},{"key":"12827_CR75","unstructured":"Courtney A, Frohman EM, Neuroimaging & Multiple Sclerosis. Multiple Sclerosis for the Physician Assistant, p\u00a021"},{"issue":"8","key":"12827_CR76","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/00207454.2022.2153046","volume":"134","author":"MA Mireles-Ram\u00edrez","year":"2022","unstructured":"Mireles-Ram\u00edrez MA et al (2022) Neuromyelitis optica spectrum disorder: pathophysiological approach. Int J Neurosci 134(8):826\u2013838","journal-title":"Int J Neurosci"},{"issue":"4","key":"12827_CR77","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hbm.25274","volume":"42","author":"E Lommers","year":"2021","unstructured":"Lommers E et al (2021) Voxel-Based quantitative MRI reveals spatial patterns of grey matter alteration in multiple sclerosis. Hum Brain Mapp 42(4):1003\u20131012","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"12827_CR78","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.25145","volume":"83","author":"A Eshaghi","year":"2018","unstructured":"Eshaghi A et al (2018) Deep gray matter volume loss drives disability worsening in multiple sclerosis. Ann Neurol 83(2):210\u2013222","journal-title":"Ann Neurol"},{"issue":"9","key":"12827_CR79","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jnnp-2020-325610","volume":"92","author":"E Colato","year":"2021","unstructured":"Colato E et al (2021) Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes. J Neurol Neurosurg Psychiatry 92(9):995\u20131006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12827_CR80","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jocn.2022.04.035","volume":"101","author":"J Patel","year":"2022","unstructured":"Patel J et al (2022) Development and validation of a simple and practical method for differentiating MS from other neuroinflammatory disorders based on lesion distribution on brain MRI. J Clin Neurosci 101:32\u201336","journal-title":"J Clin Neurosci"},{"issue":"4","key":"12827_CR81","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neurol.2022.11.004","volume":"179","author":"O Mirmosayyeb","year":"2023","unstructured":"Mirmosayyeb O et al (2023) Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: a systematic review. Revue Neurologique 179(4):265\u2013281","journal-title":"Revue Neurologique"},{"issue":"7","key":"12827_CR82","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14737175.2016.1181543","volume":"16","author":"R Zivadinov","year":"2016","unstructured":"Zivadinov R et al (2016) Clinical relevance of brain atrophy assessment in multiple sclerosis. implications for its use in a clinical routine. Expert Rev Neurotherapeutics 16(7):777\u2013793","journal-title":"Expert Rev Neurotherapeutics"},{"issue":"2","key":"12827_CR83","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/1352458508098270","volume":"15","author":"G Tedeschi","year":"2009","unstructured":"Tedeschi G et al (2009) Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study. Mult Scler J 15(2):204\u2013211","journal-title":"Mult Scler J"},{"key":"12827_CR84","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","volume":"135","author":"S Luchetti","year":"2018","unstructured":"Luchetti S et al (2018) Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis. Acta Neuropathol 135:511\u2013528","journal-title":"Acta Neuropathol"},{"issue":"4","key":"12827_CR85","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuroimage.2005.03.008","volume":"26","author":"MP Sanfilipo","year":"2005","unstructured":"Sanfilipo MP et al (2005) The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction. Neuroimage 26(4):1068\u20131077","journal-title":"Neuroimage"},{"issue":"4","key":"12827_CR86","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/jnnp.2007.120378","volume":"79","author":"D Horakova","year":"2008","unstructured":"Horakova D et al (2008) Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study. J Neurol Neurosurg Psychiatry 79(4):407\u2013414","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"12827_CR87","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jnnp-2021-326386","volume":"93","author":"H Masuda","year":"2022","unstructured":"Masuda H et al (2022) Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry 93(1):32\u201340","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"12827_CR88","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1177\/1352458519893093","volume":"26","author":"S Salama","year":"2020","unstructured":"Salama S et al (2020) MRI differences between MOG antibody disease and AQP4 NMOSD. Mult Scler J 26(14):1854\u20131865","journal-title":"Mult Scler J"},{"issue":"4","key":"12827_CR89","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp-2014-310206","volume":"87","author":"T Akaishi","year":"2016","unstructured":"Akaishi T et al (2016) MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry 87(4):446\u2013448","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7\u20138","key":"12827_CR90","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/08820538.2020.1866027","volume":"35","author":"A Winter","year":"2020","unstructured":"Winter A, Chwalisz B (2020) MRI characteristics of NMO, MOG and MS related optic neuritis. Semin Ophthalmol 35(7\u20138):333\u2013342","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"12827_CR91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/WNO.0b013e318283c3ed","volume":"33","author":"M Storoni","year":"2013","unstructured":"Storoni M et al (2013) Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system. J Neuroophthalmol 33(2):123\u2013127","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"12827_CR92","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","volume":"22","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S et al (2016) Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler J 22(4):470\u2013482","journal-title":"Mult Scler J"},{"key":"12827_CR93","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10072-014-1635-6","volume":"35","author":"Y-M Lim","year":"2014","unstructured":"Lim Y-M et al (2014) First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis. Neurol Sci 35:781\u2013783","journal-title":"Neurol Sci"},{"issue":"3","key":"12827_CR94","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/WNO.0b013e318254c62d","volume":"32","author":"S Khanna","year":"2012","unstructured":"Khanna S et al (2012) Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis. J Neuroophthalmol 32(3):216\u2013220","journal-title":"J Neuroophthalmol"},{"key":"12827_CR95","doi-asserted-by":"crossref","first-page":"100009","DOI":"10.1016\/j.rare.2023.100009","volume":"1","author":"N Ebrahimi","year":"2023","unstructured":"Ebrahimi N et al (2023) Sexual and urinary dysfunctions among patients with neuromyelitis optica spectrum disorder (NMOSD): a systematic review. Rare 1:100009","journal-title":"Rare"},{"issue":"14","key":"12827_CR96","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1177\/1352458515578888","volume":"21","author":"O Outteryck","year":"2015","unstructured":"Outteryck O et al (2015) A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler J 21(14):1781\u20131793","journal-title":"Mult Scler J"},{"key":"12827_CR97","doi-asserted-by":"crossref","first-page":"102230","DOI":"10.1016\/j.arr.2024.102230","volume":"95","author":"L Du","year":"2024","unstructured":"Du L et al (2024) Unveiling the future: advancements in MRI imaging for neurodegenerative disorders. Ageing Res Rev 95:102230","journal-title":"Ageing Res Rev"},{"key":"12827_CR98","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13167-015-0038-y","volume":"6","author":"T Sinnecker","year":"2015","unstructured":"Sinnecker T et al (2015) Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management. EPMA J 6:16","journal-title":"EPMA J"},{"key":"12827_CR99","doi-asserted-by":"crossref","first-page":"175628641985972","DOI":"10.1177\/1756286419859722","volume":"12","author":"R Cortese","year":"2019","unstructured":"Cortese R et al (2019) Advances in brain imaging in multiple sclerosis. Ther Adv Neurol Disord 12:1756286419859722","journal-title":"Ther Adv Neurol Disord"},{"key":"12827_CR100","first-page":"175628641984059","volume":"12","author":"M Moccia","year":"2019","unstructured":"Moccia M et al (2019) Advances in spinal cord imaging in multiple sclerosis. Ther Adv Neurol Disord 12:1756286419840593","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12827-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12827-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12827-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:57:52Z","timestamp":1738173472000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12827-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["12827"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12827-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This manuscript has been approved for publication by all authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"77"}}